Kim Raineri
Chief Technology Officer Aspen Neuroscience
Kim has deep global experience in the cell and gene therapy industry, biologics and medical device spaces, with a distinguished track record of innovation and implementation of Good Manufacturing Practices (GMP). Prior to joining Aspen Neuroscience, Kim served as Chief Manufacturing and Technology Officer and a member of the executive team at AVROBIO, a Boston-based leader in the gene therapy space.
Seminars
Tuesday 27th October 2026
Panel Discussion: Building a Robust Raw Material Strategy for Advanced Therapies
9:00 am
- Establishing a phase-appropriate raw material strategy that supports both early development flexibility and late-stage regulatory expectations
- Navigating evolving regulatory expectations for raw materials
- Evaluating supplier strategies, including sole vs dual sourcing, to mitigate supply chain risk while maintaining product comparability and regulatory compliance
